News

HDFCCC Joins National Effort Endorsing Updated HPV Vaccine Recommendations

Recognizing a critical need to improve national vaccination rates for the human papillomavirus (HPV), the UCSF Helen Diller Family Comprehensive Cancer Center has again united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement in support of

UCSF, Pfizer Renew Research Collaboration, Citing Progress in Drug Discovery Research

UC San Francisco and Pfizer Inc.’s Centers for Therapeutic Innovation (CTI) have renewed an agreement to identify and develop biologic compounds against both known and novel targets, including the immune system, in diseases such as cancer, cardiovascular and metabolic diseases. The collaboration

The Role of Common Risk Factors in ER-positive, ER-negative Breast Cancer

Karla Kerlikowske, MD, and team recently published a paper in the Journal of the National Cancer Institute that examined the role of common risk factors in the development of ER-positive and ER-negative breast cancers. The study sheds new light on how a woman's age, weight, and menopausal status

Search Engine: How Artificial Intelligence Techniques Are Aiding the Hunt for New Drugs

A better cure for cancer – and other illnesses – could already be in existence, hidden right under our noses. The problem is that possible new lifesaving drugs are created much faster than scientists can study them. Millions of untested compounds wait, jumbled together in no particular order in vast

UCSF Experts to Share Latest Research at 2017 Precision Medicine World Conference

For the second consecutive year, UC San Francisco is co-hosting the Precision Medicine World Conference (PMWC), which is being held in January 2017. Precision Medicine World Conference The annual forum brings together experts to speak about the latest findings across health care, data and

Year in Review: 2016

2016 has been a year of growth, partnerships and progress at the Helen Diller Family Comprehensive Cancer Center. Our researchers and clinicians, patients and families, community groups, and government and industry partners continued working to make cancer a manageable disease. Please take some time

Many Safety Net Patients Don't Complete Colonoscopy after Abnormal Stool-Based Colorectal Screening Test

Nearly half of the patients in a safety net health system who had an abnormal stool-based screening test for colorectal cancer failed to receive the recommended colonoscopy within a year, despite the benefits of an integrated health care system with access to colonoscopy and shared electronic health